Gail Holmes v. Hospira Inc.; Pfizer Inc.; Parke-Davis, a Division of Warner-Lambert Company; Warner-Lambert Company; Warner-Lambert Company LLC; Pfizer Pharmaceuticals Inc.; Johnson & Johnson; Ortho-McNeil Pharmaceutical Inc.; Johnson & Johnson Pharmaceutical Research & Development LLC; Janssen Pharmaceutica Inc.; Janssen Pharmaceuticals Inc., and
Published: Apr. 27, 2013 | Result Date: Apr. 11, 2013 | Filing Date: Jan. 1, 1900 |Case number: 5:12-cv-01708-VAP-DTB Bench Decision – Dismissal with Leave to Amend
Court
USDC Central
Attorneys
Plaintiff
Defendant
Rita M. Haeusler
(Hughes, Hubbard & Reed LLP)
Alexander G. Calfo
(King & Spalding LLP)
Ben D. Whitwell
(Venable LLP)
Facts
Gail Holmes suffered adverse reactions to Levaquin, which was prescribed to her by her doctor for strep throat. She thereafter developed Steven-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis, which were extreme severe adverse reactions that result in skin necrolysis, blistering, and mucous membrane destruction. Holmes filed a products liability action against several defendants, including Johnson & Johnson, Janssen Research & Development LLC, and Janssen Pharmaceuticals (collectively, Johnson), as well as Pfizer Inc., Pfizer Pharmaceuticals Inc., which developed, manufactured, and marketed the drug.
Result
The Johnson defendants successfully sought dismissal of some of the claims filed against them.
For reprint rights or to order a copy of your photo:
Email
jeremy@reprintpros.com
for prices.
Direct dial: 949-702-5390